Thus, the oncogenic mutations in the cytosolic IDH (IDH1) have been detected in some cancerous neoplasms, namely, acute myeloid leukemia and poorly differentiated and secondary glioblastoma [124,125], cholangiocarcinoma, chondrosarcoma, and glioma [126]. This evidence concerns the gene IDH1 and cholangiocarcinoma.